ClinConnect ClinConnect Logo
Search / Trial NCT06938308

Comparison Between the I-gel and Protector Supraglottic Airway Devices

Launched by NIKOLOPOULOU MARIA ZOZEFIN · Apr 14, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

I Gel Protector Learning Curve Lma Airway

ClinConnect Summary

This clinical trial is comparing two types of devices used to help manage a patient’s airway during surgery, specifically the I-gel and Protector supraglottic airway devices. The goal is to see how easily anesthesiology residents can learn to use these devices when placing them in adult patients. This research is important because it may help improve the safety and effectiveness of airway management during surgeries.

To be eligible for this study, participants need to be adults over 18 years old and classified as ASA I-II, which means they are generally healthy or have mild medical issues. They should be undergoing procedures while lying on their back or in a specific position called lithotomy. However, those with certain conditions like tumors in the throat, a history of difficult intubation, or limited mouth opening would not be able to participate. If someone joins the trial, they can expect to have their airway managed using one of the two devices being studied, helping researchers learn which device is easier for new anesthesiology residents to use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA I-II
  • Patients older than 18 years
  • Procedures in supine and lithotomy position
  • Exclusion Criteria:
  • Tumors or anatomical anomalies of the upper airway
  • Known history of difficult intubation
  • Limited mouth opening less than 2cm
  • Decreased compliance of the lungs or the thoracic cage
  • Need of mechanical ventilation after the surgery

About Nikolopoulou Maria Zozefin

Nikolopoulou Maria Zozefin is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on ethical practices and patient safety, the organization designs and manages clinical trials that contribute to the development of new therapies and treatment protocols. Leveraging a multidisciplinary team of experts, Nikolopoulou Maria Zozefin emphasizes collaboration and transparency throughout the research process, ensuring compliance with regulatory standards and fostering partnerships with healthcare institutions and research organizations. Their mission is to enhance healthcare outcomes through rigorous scientific inquiry and the promotion of evidence-based medicine.

Locations

Athens, Attiki, Greece

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported